← Back to all trials
Completed
NCT01987999
A Nutraceutical Intervention in Patients With Previously Untreated Human Prostate Cancer
Conditions: Prostate Cancer
Sex: Male
Ages: 40 Years – 75 Years
Healthy volunteers: No
Phase: PHASE2
Enrollment: 60
Sponsor: Optimal Health Research
Summary
The purpose of this study is to evaluate weather a novel nutraceutical intervention (F-989) can improve prostate-specific antigerm (PSA) levels and Gleason scores in prostate cancer patients who are on active surveillance.
Eligibility Criteria
Inclusion Criteria:
* Clinical diagnosis of prostate cancer (PSA + biopsy)
* Referred to the study by their treating physician
Exclusion Criteria:
\- Any type of treatment before starting the study
Source: ClinicalTrials.gov (NCT01987999). StuddyBuddy aggregates publicly available trial information.